Evolution of DS-1-like human G2P[4] rotaviruses assessed by complete genome analyses by Giammanco, G. et al.
Evolution of DS-1-like human G2P[4] rotaviruses
assessed by complete genome analyses
Giovanni M. Giammanco,1 Floriana Bonura,1 Mark Zeller,2
Elisabeth Heylen,2 Marc Van Ranst,2 Vito Martella,3 Kristia´n Ba´nyai,4
Jelle Matthijnssens2 and Simona De Grazia1
Correspondence
Giovanni M. Giammanco
giovanni.giammanco@unipa.it
Received 3 July 2013
Accepted 23 September 2013
1Dipartimento di Scienze per la Promozione della Salute ‘G. D’Alessandro’, Universita` di Palermo,
Italy
2Laboratory of Clinical and Epidemiological Virology, Department of Microbiology and Immunology,
Rega Institute for Medical Research, University of Leuven, Leuven, Belgium
3Dipartimento di Sanita` Pubblica e Zootecnia, Universita` Aldo Moro di Bari, Valenzano, Italy
4Institute for Veterinary Medical Research, Centre for Agricultural Research,
Hungarian Academy of Sciences, Budapest, Hungary
Group A rotaviruses (RVAs) are a leading cause of viral gastroenteritis in children, with G2P[4]
RVA being one of the most common human strains worldwide. The complete genome sequences
of nine G2P[4] RVA strains, selected from a 26-year archival collection (1985–2011) established
in Palermo, Italy, were determined. A strain associated with a peak of G2P[4] RVA activity in 1996
resembled a reassortant strain identified in Kenya in 1982 and differed completely in genomic
make up from more recent strains that circulated during 2004–2011. Conversely, the 2004–
2011 G2P[4] RVAs were genetically more similar to contemporary RVA strains circulating
globally. Recent G2P[4] strains possessed either single or multiple genome segments (VP1, VP3
and/or NSP4) likely derived from ruminant viruses through intra-genotype reassortment. Amino
acid substitutions were selected and maintained over time in the VP7 and VP8* antigenic proteins,
allowing the circulation of two contemporary G2P[4] variants to be distinguished. Altogether,
these findings suggest that major changes in the genomic composition of recent G2P[4] RVAs
occurred in the early 2000s, leading to the appearance of a novel variant of the DS-1-like
genotype constellation. Whether the modifications observed in the neutralizing antigens and in the
genome composition of modern G2P[4] RVAs may affect the long-term effectiveness of the
vaccination programmes remains to be explored.
INTRODUCTION
Group A rotaviruses (RVAs), family Reoviridae, are major
pathogens causing gastroenteritis in young children, with a
mortality rate of 453 000 deaths annually (Tate et al., 2012).
RVA has a double-stranded RNA genome made of 11
segments which encode six structural proteins (VP1–VP4,
VP6 and VP7) and six non-structural proteins (NSP1–
NSP6) (Estes & Kapikian, 2007). Based on the constellation
of segments composing the genome, three human geno-
types have been established: Wa-like (genotype con-
stellation 1), DS-1-like (genotype constellation 2) and
AU-1-like (genotype constellation 3) (Matthijnssens et al.,
2008a; Nakagomi & Nakagomi, 1989). RVA strains are
classified into G- and P-types based on genetic and
antigenic diversity of the two outer capsid proteins, VP7
(G-genotypes) and VP4 (P-genotypes), respectively (Estes
& Kapikian, 2007). To date, 27 different G- and 37 P-
genotypes have been described in humans and animals
(Matthijnssens et al., 2011; Trojnar et al., 2013). The
majority of RVAs infecting humans are: G1P[8], G2P[4],
G3P[8], G4P[8], G9P[8] and G12P[8] (Ba´nyai et al., 2012;
Santos & Hoshino, 2005). The segmented nature of the
RVA genome enables assortment of different individual
gene segments of parental virus strains during mixed
infections, generating reassortant virus strains. In 2008,
the Rotavirus Classification Working Group (RCWG)
The GenBank/EMBL/DDBJ accession numbers for the nine G2P[4]
RVA complete genome sequences determined in this work are
KC178763–KC178771 (for VP1), KC178772–KC178780 (VP2),
KC178781–KC178789 (VP3), KC178790–KC178798 (VP4),
KC178799–KC178807 (VP6), KC178808–KC178816 (VP7),
KC178718–KC178726 (NSP1), KC178727–KC178735 (NSP2),
KC178736–KC178744 (NSP3), KC178745–KC178753 (NSP4) and
KC178754–KC178762 (NSP5).
A supplementary figure is available with the online version of this paper.
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proposed a full genome-based classification scheme allow-
ing the differentiation of genotypes for the 11 RVA RNA
segments, providing an ideal platform for deciphering the
complex genetic diversity of RVAs (Matthijnssens et al.,
2008a,b).
Although the global prevalence rate of G2P[4] strains is
lower than that of G1P[8] strains, G2P[4] RVAs are
recognized as a common cause of viral diarrhoea in
humans, frequently reaching an epidemiological predomi-
nance in some geographical areas (Antunes et al., 2009;
Chouikha et al., 2011; Dey et al., 2009; Doan et al., 2011;
Iturriza-Go´mara et al., 2011; Kirkwood et al., 2009; Paul
et al., 2008; Santos & Hoshino, 2005; Todd et al., 2010).
Notably, increased circulation of G2P[4] strains has been
signalled after the introduction of RVA vaccination in
several countries (Gurgel et al., 2007; Nakagomi et al.,
2008; Zeller et al., 2010), although epidemiological
investigations in South America have revealed that an
increase in the circulation of G2P[4] RVA strains also
occurred in the same time frames in countries in which no
universal RVA vaccination programmes were established
(Gurgel et al., 2007; Matthijnssens et al., 2009, 2012).
Although it is very likely that vaccination will have some
effect on the genotype distribution of circulating RVA
strains, it is unclear what the long-term effects of this
vaccine-derived selective pressure will be compared with
other factors shaping natural genotype fluctuations
(Matthijnssens et al., 2012).
VP7 sequence analysis of G2 RVAs detected over a 35-
year period revealed that G2 VP7 lineages follow
temporal patterns of evolution. The oldest G2 strains,
sharing the same lineage (G2-I) as the prototype strain
DS-1, were not detected after 1990, while a lineage of G2
RVAs (G2-II) circulated for almost 15 years between 1991
and 2005. In the 1990s a novel variant of a distinct lineage
emerged (IVa-1) and spread all over the world, followed
by another lineage IV variant (IVa-3) in the 2000s.
Virtually all the G2 RVAs detected in the last decade
(2001–2009) belong to those two variants (Doan et al.,
2011).
RVA surveillance in Palermo, Italy, has been conducted
uninterruptedly since 1985, revealing yearly prevalence
rates of RVAs ranging from 20% to 50% among children
aged,5 years hospitalized with gastroenteritis (Arista et al.,
1986, 1990, 1997, 2003, 2004, 2005; De Grazia et al., 2007).
In the 26-year period 1985–2011, the prevalence of G2P[4]
RVAs in the paediatric population of Palermo showed
yearly fluctuations (Arista et al., 2005; De Grazia et al.,
2007), with peaks in 1985, 1996 to 1998, 2003 and 2004,
2006 to 2008, 2010 and 2011 (Fig. 1). Interestingly, the G2
strains identified between 2002 and 2004 did not react with
the G2 type-specific monoclonal antibody (mAb) RV5 : 3,
which was related to a change (D to N) in antigenic region
A at residue 96 (Arista et al., 2005) and is a hallmark of all
recent G2 RVAs (lineage IVa) (Doan et al., 2011). In order
to explore in more detail the observed antigenic/genetic
diversity in G2P[4] RVAs and to understand whether these
changes were limited to the outer capsid proteins or also
affected the overall genetic structure, the complete
genomes of nine selected G2P[4] RVA strains isolated in
Palermo, Italy, between 1996 and 2011 were determined.
METHODS
Sample collection. Uninterrupted surveillance on RVA circulation
has been conducted in Palermo, southern Italy, for 26 years (1985–
2011). Stool samples were collected from children under 5 years
admitted at the ‘G. Di Cristina’ Children’s Hospital of Palermo for
acute gastroenteritis. Since the rotavirus season in Palermo is
generally delayed with respect to the usual winter peak and includes
the end of winter and spring (the peak circulation is in March and
April), this paper is written using years instead of seasons.
Nucleic acid extraction and G- and P-genotyping by semi-
nested PCR. Viral RNA was extracted from 10% faecal suspension
using a QIAamp Viral RNA mini kit (Qiagen), according to the
manufacturer’s instructions.
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Fig. 1. Circulation of RVA genotypes in Palermo, Italy, from 1985 to 2011. Arrows indicate the year of collection and number of
G2P[4] isolates selected for whole genome analysis.
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Table 1. Comparison of the genomic constellations of the Italian G2P[4] RVA strains analysed in this study (in bold) and other RVA strains belonging to the DS-1 genogroup
Colour codes indicate lineage attribution as described in Fig. 2. Gold is used for segments belonging to the lineage constellation of the ancestor DS-1 strain, violet for those belonging to the PAI11/
1996 lineage constellation and red for those belonging to the lineage constellation of the G2P[4] RVA strains isolated in Palermo in the 2000s. Orange, yellow, purple and pink shades indicate
genotype 2 segments belonging to human RVAs but not related to the three previously described lineage constellations. Different blue and green shades indicate segments of animal origin. Grey
indicates the genotype 2 segments typical of the vaccine strain SC2-9.
VP7 VP4 VP6 VP1 VP2 VP3 NSP1 NSP2 NSP3 NSP4 NSP5
RVA/Human-tc/USA/DS-1/1976/G2P1B[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2 Human
RVA/Human-tc/KEN/AK26/1982/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N1 T2 E2 H2
RVA/Human-tc/KEN/D205/1989/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/AUS/95A/1995/G2Px Human G2
RVA/Human-wt/CHN/TB-Chen/1996/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/ZAF/64SB/1996/G2P[4] Human G2
RVA/Human-wt/ITA/PAI11/1996/G2P4 Human G2 P[4] I2 R2 C2 M2 A2 N1 T2 E2 H2
RVA/Human-wt/ZAF/906SB/1998/G2P[6] Human G2
RVA/Human-wt/ZAF/GR10924/1999/G9P[6] Human G9 P[6] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/BGD/RV161/2000/G12P[6] Human G12 P[6] I2 R2 C2 M2 A2 N2 T2 E1 H2
RVA/Human-wt/MWI/1473/2001/G8P[4] Human G8 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/BEL/B1711/2002/G6P[6] Human G6 P[6] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/BGD/N26/2002/G12P[6] Human G12 P[6] I2 R2 C2 M2 A2 N1 T2 E6 H2
RVA/Human-wt/COD/DRC88/2003/G8P[8] Human G8 P[8] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/ITA/PA3/2004/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/BGD/MMC88/2005/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/USA/LB2772/2005/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/BGD/MMC6/2005/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/ITA/PA150/2006/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/IND/265/2007/G10P[6] Human E2
RVA/Human-wt/ITA/PA83/2007/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/ITA/PA108/2007/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/ITA/PA84/2008/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/ITA/PA17/2008/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/RUS/Omsk08-475/2008/G2P[4] Human G2 P[4] I2 E2
RVA/Human-wt/IND/UP-BE-1/2009/GxPx Human E2
RVA/Human-wt/DEU/GER1H/2009/G8P[4] Human G8 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/ZAF/3203WC/2009/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/BEL/F01322/2009/G3P[6] Human G3 P[6] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/ITA/PA130/2010/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/ITA/PA133/2011/G2P[4] Human G2 P[4] I2 R2 C2 M2 A2 N2 T2 E2 H2
RVA/Human-wt/HUN/Hun5/1997/G6P[14] Human G6 P[14] I2 R2 C2 M2 A11 N2 T6 E2 H3 Animal or
animal-derivedRVA/Goat-tc/BGD/GO34/1999/G6P[1] Goat G6 P[1] I2 R2 C2 M2 A11 N2 T6 E2 H3
RVA/Human-wt/HUN/BP1879/2003/G6P[14] Human G6 P[14] I2 R2 C2 M2 A11 N2 T6 E2 H3
RVA/Human-wt/HUN/BP1062/2004/G8P[14] Human G8 P[14] I2 R2 C2 M2 A11 N2 T6 E2 H3
RVA/Cow-wt/IND/MP/B-47/2008/GxPx Cow E2
RVA/Cow-wt/IND/MP-B-100/2008/GxPx Cow E2
RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7[5] Human/cow G2 P7[5] I2 R2 C2 M1 A3 N2 T6 E2 H3 Vaccine
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 HQ657176_RVA/Human-wt/ZAF/3203WC/2009/G2P[4]
 HM467955_RVA/Human-wt/USA/LB2764/2005/G2P[4]
 KC178814_RVA/Human-wt/ITA/PA17/2008/G2P[4]
 KC178813_RVA/Human-wt/ITA/PA108/2007/G2P[4]
 EU839923_RVA/Human-wt/BGD/MMC6/2005/G2P[4]
EU839925_RVA/Human-wt/BGD/MMC88/2005/G2P[4]
78
VP7
 KC178816_RVA/Human-wt/ITA/PA133/2011/G2P[4]
 KC178808_RVA/Human-wt/ITA/PA130/2010/G2P[4]
 GQ463712 HRV/Human-wt/RUS/Omsk08-475/2008/G2P[4]
 KC178812_RVA/Human-wt/ITA/PA83/2007/G2P[4]
 KC178815_RVA/Human-wt/ITA/PA84/2008/G2P[4]
 DQ321493_RVA/Human-wt/CHN/XJ00-486/2000/G2P[6]
a-3
IV
74
80
 KC178810_RVA/Human-wt/ITA/PA3/2004/G2P[4]
 HM467953_RVA/Human-wt/USA/LB2744/2005/G2P[4]
 KC178811_RVA/Human-wt/ITA/PA150/2006/G2P[4]
 HM467956_RVA/Human-wt/USA/LB2772/2005/G2P[4]
a-1
 AY261354_RVA/Human-wt/CIV/CI1735/1999/G2P[4]
 AY261355_RVA/Human/BFA/BF3767/1999/G2P[4]
a-2
AY787646_RVA/Human-wt/CHN/TB-Chen/1996/G2P[4]
G2
100
71
70
81
82
 M11164_RVA/Human/JPN/S2/G2P[4]
 D50127_RVA/Human/JPN/TMCII/1980/G2P[4]
 D50124 RVA/Human/JPN/KUN/1980/G2P[4]
III
 EF672581_RVA/Human-tc/USA/DS-1/1976/G2P[4]
 AY261335_RVA/Human/ZAF/410GR/1985/G2P[4]
 AY261338_RVA/Human/ZAF/514GR/1987/G2P[4]
I
96
99
100
79
80
92
91
 AY261347_RVA/Human-wt/ZAF/906SB/1998/G2P[6]
 AY261341_RVA/Human-wt/64SB/1996/G2P[4]
 JF304931_RVA/Human-tc/KEN/AK26/1982/G2P[4]
 U73955_RVA/Human-wt/AUS/95A/1995/G2Px
 KC178809_RVA/Human-wt/ITA/PAI11/1996/G2P[4]
 GU565068 RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7[5]
II
72
94
79
75
G3JF460828 RVA/Human-wt/BEL/F01322/2009/G3P[6]
 DQ490550_RVA/Human-wt/BGD/RV161/2000/G12P[6]
 DQ490556_RVA/Human-wt/BGD/RV176/2000/G12P[6]
 DQ146687_RVA/Human-wt/BGD/N26/2002/G12P[6]
G12
 EF554087_RVA/Human-wt/BEL/B1711/2002/G6P[6]
 GU937882 RVA/Goat-wt/BGD/GO34/1999/G6P[1]
 FN665685 RVA/Human-wt/HUN/BP1879/2003/G6P[14]
G6
100
85
83
EF554109 RVA/Human-wt/HUN/Hun5/1997/G6P[14]
G9 FJ183360_RVA/Human-wt/ZAF/GR10924/1999/G9P[6]
 GQ414545_RVA/Human-wt/DEU/GER1H/2009/G8P[4]
 FN665696 RVA/Human-wt/HUN/BP1062/2004/G8P[14]
 HQ657143_RVA/Human-wt/MWI/1473/2001/G8P[4]
 DQ005109_RVA/Human-wt/COD/DRC88/2003/G8P[8]
 DQ005120_RVA/Human-wt/COD/DRC86/2003/G8P[6]
G8
98
100
79
93
G18RO1OCPVP7 RVA/Pigeon-tc/JPN/PO-13/1983/G18P[17]
0.05
JF460817_RVA_Human-wt/USA/06-242/2006/G2P[6]
JF304920_RVA/Human-tc/KEN/D205/1989/G2P[4]
(a)
Fig. 2. Phylogenetic trees based on the full-length nucleotide sequences of RVA VP7 (a), VP4 (b), VP6 (c), VP1 to VP3 (d–f),
and NSP1 to NSP5 (g–k) genes. Bootstrap values (1000 replicates) above 69% are shown at branch nodes. The number of
nucleotide substitutions per site is indicated by the scale bars. The strains analysed in this study are marked with a triangle. VP7
lineages and sublineages of G2 strains and VP4 lineages of P[4] strains are indicated according to Doan et al. (2011, 2012).
NSP2 lineages within the N1 genotype are indicated according to Donker et al. (2011).
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The extracted RNA was reverse transcribed as previously described
(Iturriza-Gomara et al., 1999). Rotavirus G- and P-genotyping was
performed using semi-nested multiplex PCRs (Gentsch et al., 1992;
Gouvea et al., 1990; Iturriza-Go´mara et al., 2004; Martella et al.,
2004). All strains typable by reverse transcription-polymerase chain
reaction (RT-PCR) were further investigated by direct sequencing of
VP7 and VP4 for phylogenetic analysis.
Whole genome sequencing and phylogenetic analysis. A
selection of G2P[4] strains representative of the surveillance period,
for which a sufficient amount of the original faecal sample was available,
was subjected to whole genome analysis (Fig. 1). The complete genome
sequencing, including the 59 and 39 termini of each genome segment, of
the selected RVA strains was performed as described elsewhere
(Matthijnssens et al., 2006). The genotypes of the G2P[4] RVA strains
were determined according to the genotyping recommendations of the
RCWGusing the RotaC online classification tool (http://rotac.regatools.
be) (Maes et al., 2009). Cognate genome sequences were individually
compared with whole genome RVA sequences available in GenBank.
When reassortment was suspected, the most similar sequences available
in GenBank were also added to the corresponding tree even if sequences
of other gene segments were not available. Phylogenetic analysis was
performed using the software MEGA5 (Tamura et al., 2011). Phylogenetic
trees were constructed using the neighbour-joining method and
VP4
 
 KC178791_RVA/Human-wt/ITA/PA133/2011/G2P[4]
 GQ463711 HRV/Human-wt/RUS/Omsk08-475/2008/G2P[4]
 KC178790_RVA/Human-wt/ITA/PA130/2010/G2P[4]
 HM467943_RVA/Human-wt/USA/LB2764/2005/G2P[4]
 EU839950_RVA/Human-wt/BGD/MMC6/2005/G2P[4]
 KC178796_RVA/Human-wt/ITA/PA108/2007/G2P[4]
b
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 HQ641373_RVA/Human-wt/BGD/MMC88/2005/G2P[4]
 KC178797_RVA/Human-wt/ITA/PA17/2008/G2P[4]
 KC178793_RVA/Human-wt/ITA/PA3/2004/G2P[4]
 KC178798_RVA/Human-wt/ITA/PA84/2008/G2P[4]
 GQ414543_RVA/Human-wt/DEU/GER1H/2009/G8P[4]
 KC178794_RVA/Human-wt/ITA/PA150/2006/G2P[4]
 HQ657174_RVA/Human-wt/ZAF/3203WC/2009/G2P[4]
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IV
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 HM467941_RVA/Human-wt/USA/LB2744/2005/G2P[4]
 HM467945_RVA/Human-wt/USA/LB2772/2005/G2P[4]
 AY787644_RVA/Human-wt/CHN/TB-Chen/1996/G2P[4]
 DQ172838_RVA/Human-wt/ITA/PAH41/1993/G2P[4]
III AB733131 RVA/Human-tc/JPN/KUN/1980/G2P[4]
I HQ650119_RVA/Human-tc/USA/DS-1/1976/G2P[4]
98
100
98
87
 JF304929_RVA/Human-tc/KEN/AK26/1982/G2P[4]
 JF304918_RVA/Human-tc/KEN/D205/1989/G2P[4]
 HQ657141_RVA/Human-wt/MWI/1473/2001/G8P[4]
II
P[8] DQ005111_RVA/Human-wt/COD/DRC88/2003/G8P[8]
 DQ005122_RVA/Human-wt/COD/DRC86/2003/G8P[6]
 EF554085_RVA/Human-wt/BEL/B1711/2002/G6P[6]83
100
98
100
97
82
 
 FJ183356_RVA/Human-wt/ZAF/GR10924/1999/G9P[6]
 DQ146685_RVA/Human-wt/BGD/N26/2002/G12P[6]
 DQ490548_RVA/Human-wt/BGD/RV161/2000/G12P[6]
 DQ490554_RVA/Human-wt/BGD/RV176/2000/G12P[6]
P[6]
P7[5] GU565066 RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7[5]
P[1] GU937880 RVA/Goat-wt/BGD/GO34/1999/G6P[1]
95
FN665691 RVA/Human-wt/HUN/BP1062/2004/G8P[14]
 FN665680 RVA/Human-wt/HUN/BP1879/2003/G6P[14]
P[14]
P[17] AB009632 RVA/Pigeon-tc/JPN/PO-13/1983/G18P[17]
100
0.05
(b) KC178795_RVA/Human-wt/ITA/PA83/2007/G2P[4]
 KC178792_RVA/Human-wt/ITA/PAI11/1996/G2P[4]
JF460826 RVA/Human-wt/BEL/F01322/2009/G3P[6]
Fig. 2. (continued)
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Kimura’s two-parameter model with 1000 bootstrap replicates. Lineage
designation for the various genome segments followed the outlines of
the existing literature and was substantiated by sequence comparison
and phylogenetic analysis of our sequence datasets.
Accession numbers. GenBank accession numbers for each indi-
vidual genomic segment are: KC178763–KC178771 (VP1); KC178772–
KC178780 (VP2); KC178781–KC178789 (VP3); KC178790–KC178798
(VP4); KC178799–KC178807 (VP6); KC178808–KC178816 (VP7);
KC178718–KC178726 (NSP1); KC178727–KC178735 (NSP2); KC178736–
KC178744 (NSP3); KC178745–KC178753 (NSP4); KC178754–
KC178762 (NSP5).
RESULTS
Representative G2P[4] strains were selected on the basis
of preliminary phylogenetic analysis of 38 partial VP7
sequences (.456 nt in length) detected between 1993 and
2011. We were not able to produce sequences from strains
from before 1993 (Fig. S1, available in JGV Online). Nine
G2 RVA strains, detected in seven different years of
increased G2P[4] circulation, 1996 (PAI11/1996), 2004
(PA3/2004), 2006 (PA150/2006), 2007 (PA83/2007 and
PA108/2007), 2008 (PA17/2008 and PA84/2008), 2010
 KC178800_RVA/Human-wt/ITA/PA3/2004/G2P[4]
 KC178805_RVA/Human-wt/ITA/PA84/2008/G2P[4]
 KC178801_RVA/Human-wt/ITA/PA150/2006/G2P[4]
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VP6
 DQ490549_RVA/Human-wt/BGD/RV161/2000/G12P[6]
 DQ490555_RVA/Human-wt/BGD/RV176/2000/G12P[6]
 EF554086_RVA/Human-wt/BEL/B1711/2002/G6P[6]
 JF460827 RVA/Human-wt/BEL/F01322/2009/G3P[6]
JF460816_RVA/Human-wt/USA/06-242/2006/G2P[6]
VII
98
99
96
81
78
 HQ657175_RVA/Human-wt/ZAF/3203WC/2009/G2P[4]
 KC178802_RVA/Human-wt/ITA/PA83/2007/G2P[4]
 GQ477113_HRV/Human-wt/RUS/Omsk08-475/2008/G2P[4]
 KC178806_RVA/Human-wt/ITA/PA133/2011/G2P[4]
I2
89
72
87
 KC178803_RVA/Human-wt/ITA/PA108/2007/G2P[4]
 KC178807_RVA/Human-wt/ITA/PA130/2010/G2P[4]
 FJ183358_RVA/Human-wt/ZAF/GR10924/1999/G9P[6]
VI
93
100
99
92
95
V GU937881 RVA/Goat-wt/BGD/GO34/1999/G6P[1]
IX
VIII
III GU565067 RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7[5]
87
93
90
 DQ870507_RVA/Human-tc/USA/DS-1/1976/G2P[4]
 AY787645_RVA/Human-wt/CHN/TB-Chen/1996/G2P[4]
 DQ870488_RVA/Human-tc/JPN/S2/1980/G2P1B[4]
I
II
IV
I4 D16329 RVA/Pigeon-tc/JPN/PO-13/1983/G18P17
100
100
100
0.05
(c)
 GQ414544_RVA/Human-wt/DEU/GER1H/2009/G8P[4]
 HM467947_RVA/Human-wt/USA/LB2744/2005/G2P[4]
 HM467951_RVA/Human-wt/USA/LB2772/2005/G2P[4]
KC178804_RVA/Human-wt/ITA/PA17/2008/G2P[4]
 HQ657142_RVA/Human-wt/MWI/1473/2001/G8P[4]
 HQ641367_RVA/Human-wt/BGD/MMC88/2005/G2P[4]
 HM467949_RVA/Human-wt/USA/LB2764/2005/G2P[4]
 HQ641358_RVA/Human-wt/BGD/MMC6/2005/G2P[4]
 DQ005110_RVA/Human-wt/COD/DRC88/2003/G8P[8]
 DQ005121_RVA/Human-wt/COD/DRC86/2003/G8P[6]
DQ146686_RVA/Human-wt/BGD/N26/2002/G12P[6]
 FN665693 RVA/Human-wt/HUN/BP1062/2004/G8P[14]
 FN665682 RVA/Human-wt/HUN/BP1879/2003/G6P[14]
 KC178799_RVA/Human-wt/ITA/PAI11/1996/G2P[4]
 JF304930_RVA/Human-tc/KEN/AK26/1982/G2P[4]
 JF304919_RVA/Human-tc/KEN/D205/1989/G2P[4]
 EF554108 RVA/Human-wt/HUN/Hun5/1997/G6P[14]
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(PA130/2010) and 2011 (PA133/2011), were chosen for
complete genome analysis. Although the same VP7 gene
can be found in different genetic backgrounds, the nine
strains were selected as representative of the various VP7
lineages, and of clusters within different lineages, as
detected over the 1993–2011 surveillance period (Fig. S1).
Once complete genome sequences were obtained, the
genotype for each of the 11 gene segments was defined
using the online RVA classification tool RotaC at http://
rotac.regatools.be (Maes et al., 2009). This analysis
allowed unambiguous genotype assignment of all Italian
G2P[4] strains as G2-P[4]-I2–R2–C2–M2–A2–N2–T2–E2–
H2, except for strain PAI11/1996, which possessed an N1
NSP2 genotype. Complete genotype assignments of the
Italian strains, together with those of other representative
G2P[4] RVA strains, including reference strain DS-1, are
shown in Table 1.
Phylogenetic trees of all 11 genome segments were
constructed (Fig. 2). Overall, the VP1–VP4, VP6–VP7
 HM467925 RVA/Human-wt/USA/LB2744/2005/G2P[4]97
82
VP1
 KC178766 RVA/Human-wt/ITA/PA150/2006/G2P[4]
 HQ657171 RVA/Human-wt/ZAF/3203WC/2009/G2P[4]
 KC178765 RVA/Human-wt/ITA/PA3/2004/G2P[4]
 GQ414540 RVA/Human-wt/DEU/GER1H/2009/G8P[4]
 FJ183353 RVA/Human-wt/ZAF/GR10924/1999/G9P[6]
100
100
99
72
 KC178770 RVA/Human-wt/ITA/PA84/2008/G2P[4]
 JF460823 RVA/Human-wt/BEL/F01322/2009/G3P[6]
 JF460812 RVA/Human-wt/USA/06-242/2006/G2P[6]
 KC178768 RVA/Human-wt/ITA/PA108/2007/G2P[4]
 HQ641364 RVA/Human-wt/BGD/MMC88/2005/G2P[4]
VI
100
100
99
98
100
92
 KC178763 RVA/Human-wt/ITA/PA130/2010/G2P[4]
 HM467926 RVA/Human-wt/USA/LB2764/2005/G2P[4]
 DQ146682 RVA/Human-wt/BGD/N26/2002/G12P[6]
 DQ490545 RVA/Human-wt/BGD/RV161/2000/G12P[6]
 DQ490551 RVA/Human-wt/BGD/RV176/2000/G12P[6]
 KC178767 RVA/Human-wt/ITA/PA83/2007/G2P[4]
R2
76
100 82
81
98
 GU937877 RVA/Goat-wt/BGD/GO34/1999/G6P[1]
 KC178769 RVA/Human-wt/ITA/PA17/2008/G2P[4]
 KC178771 RVA/Human-wt/ITA/PA133/2011/G2P[4]
VII
VIII EF554082 RVA/Human-wt/BEL/B1711/2002/G6P[6]
 DQ870505 RVA/Human-tc/USA/DS-1/1976/G2P[4]
I
100
100
99
79
100
96
IX
III GU565063 RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7[5]
V
IV KC178764 RVA/Human-wt/ITA/PAI11/1996/G2P[4]
 JF304926 RVA/Human-tc/KEN/AK26/1982/G2P[4]
100
100
 JF304915 RVA/Human-tc/KEN/D205/1989/G2P[4]
 HQ657138 RVA/Human-wt/MWI/1473/2001/G8P[4]
II
R4 AB009629 RVA/Pigeon-tc/JPN/PO-13/1983/G18P[17]
100
100
0.05
(d)
HM467927 RVA/Human-wt/USA/LB2772/2005/G2P[4]
 DQ005114 RVA/Human-wt/COD/DRC88/2003/G8P[8]
 DQ005125 RVA/Human-wt/COD/DRC86/2003/G8P[6]
HQ641355 RVA/Human-wt/BGD/MMC6/2005/G2P[4]
 AY787653 RVA/Human-wt/CHN/TB-Chen/1996/G2P[4]
DQ870485 RVA/Human-tc/JPN/S2/1980/G2P1B[4]
 FN665688 RVA/Human-wt/HUN/BP1062/2004/G8P[14]
 EF554104 RVA/Human-wt/HUN/Hun5/1997/G6P[14]
 FN665677 RVA/Human-wt/HUN/BP1879/2003/G6P[14]
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and NSP1–NSP5 gene segments of the Italian G2P[4]
strains showed a variable degree of sequence identity,
ranging from .81.6% (at nt level) for NSP2 to .95% for
NSP3. As a general rule, for each genome, segment lineages
were defined ad hoc based on observed clustering patterns
in the phylogeny and indicated with roman numerals, but
for VP7, VP4 and NSP2 N1 genotypes the same lineage
designations were used as defined by Doan et al. (2011,
2012) and Donker et al. (2011), respectively (Fig. 2).
Lineage attribution is shown in Table 1 using colour coding
to distinguish segments belonging to different lineages
from each other and indicating the main lineage constella-
tions. According to the proposed lineage segregation, none
of the Italian strains matched the genetic pattern of the
prototype DS-1 strain isolated in the 1970s. Also, in the
VP7 tree all the analysed viruses, except for strain PAI11/
1996, were only distantly related to the G2-reassortant
vaccine strain SC2-9. Strain PAI11/1996 showed a close
phylogenetic clustering with AK26 Kenyan strain in all
genome segments with the exception of VP1, NSP2 and
NSP4 (Fig. 2). Several genome segments of PAI11/1996
were also related to another Kenyan strain, D205 (VP2,
 KC178778 RVA/Human-wt/ITA/PA108/2007/G2P[4]
 KC178772 RVA/Human-wt/ITA/PA130/2010/G2P[4]98
 KC178773 RVA/Human-wt/ITA/PA133/2011/G2P[4]
 HQ641365 RVA/Human-wt/BGD/MMC88/2005/G2P[4]
 HQ641356 RVA/Human-wt/BGD/MMC6/2005/G2P[4]
 KC178779RVA/Human-wt/ITA/PA17/2008/G2P[4]
 FJ183354 RVA/Human-wt/ZAF/GR10924/1999/G9P[6]
 DQ005113 RVA/Human-wt/COD/DRC88/2003/G8P[8]
100
71
93
100
VP2
 HM467932 RVA/Human-wt/USA/LB2764/2005/G2P[4]
 KC178777 RVA/Human-wt/ITA/PA83/2007/G2P[4]
 KC178780 RVA/Human-wt/ITA/PA84/2008/G2P[4]
 KC178775 RVA/Human-wt/ITA/PA3/2004/G2P[4]
 GQ414541 RVA/Human-wt/DEU/GER1H/2009/G8P[4]
VIII99
100
97
99
 HM467931 RVA/Human-wt/USA/LB2744/2005/G2P[4]
 HM467933 RVA/Human-wt/USA/LB2772/2005/G2P[4]
 DQ490546 RVA/Human-wt/BGD/RV161/2000/G12P[6]
 DQ146683 RVA/Human-wt/BGD/N26/2002/G12P[6]
 DQ490552 RVA/Human-wt/BGD/RV176/2000/G12P[6]
 HQ657172 RVA/Human-wt/ZAF/3203WC/2009/G2P[4]
C2
96
100
99
96
77
86
 JF460824 RVA/Human-wt/BEL/F01322/2009/G3P[6]
 JF460813 RVA/Human-wt/USA/06-242/2006/G2P[6]
 HQ657139 RVA/Human-wt/MWI/1473/2001/G8P[4]
 EF554083 RVA/Human-wt/BEL/B1711/2002/G6P[6]
 AY787652 RVA/Human-wt/CHN/TB-Chen/1996/G2P[4]
 DQ870486 RVA/Human-tc/JPN/S2/1980/G2P1B[4]
II
I
100
99
100
100
96
IV JF304916 RVA/Human-tc/KEN/D205/1989/G2P[4]
 KC178774 RVA/Human-wt/ITA/PAI11/1996/G2P[4]
 JF304927 RVA/Human-tc/KEN/AK26/1982/G2P[4]
III
VII GU937878 RVA/Goat-wt/BGD/GO34/1999/G6P[1]
X FN665689 RVA/Human-wt/HUN/BP1062/2004/G8P[14]
IX
84
78
99
99
97
VI EF554105 RVA/Human-wt/HUN/Hun5/1997/G6P[14]
V GU565064 RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7[5]
C4 AB009630 RVA/Pigeon-tc/JPN/PO-13/1983/G18P[17]
100
95
0.05
(e)
DQ005124 RVA/Human-wt/COD/DRC86/2003/G8P[6]
KC178776 RVA/Human-wt/ITA/PA150/2006/G2P[4]
HQ650117 RVA/Human-tc/USA/DS-1/1976/G2P[4]
FN665678 RVA/Human-wt/HUN/BP1879/2003/G6P[14]
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VP4, VP7 and NSP5), to the Malawian strain MWI/1473
(VP4) and, in VP7, to G2 strains from South Africa (64SB
and 906SB) and Australia (95A) (Table 1). For the other
eight Italian G2P[4] strains, detected between 2004 and
2011, all genome segments clustered separately from those
of strain PAI11/1996. Strains PA3/2004 and PA150/2006
formed a novel lineage constellation, which was shared also
by RVA strains detected in different continents – MMC6
from Bangladesh, 3203WC from South Africa and LB2772
from the USA – suggesting a worldwide circulation of this
lineage constellation within the DS-1-like RVA strains. The
most recent Italian strains, PA83/2007, PA108/2007, PA17/
2008, PA84/2008, PA130/2010 and PA133/2011, also
retained a lineage constellation very similar to the former,
although exhibiting one or more segments of different
origin. Strains PA83/2007, PA17/2008 and PA133/2011
share their VP1 and VP3 reassortant segments with the
caprine strain GO34 and the reassortant human strain
MMC88, both from Bangladesh (Fig. 2d, f, Table 1). Strain
PA130/2010 displayed a VP3 similar to the Hungarian
animal-like human RVA strain BP1062 (Fig. 2f, Table 1)
(Ba´nyai et al., 2010). The 2004–2011 G2P[4] strains
 KC178786 RVA/Human-wt/ITA/PA108/2007/G2P[4]
 KC178787 RVA/Human-wt/ITA/PA17/2008/G2P[4]
 HQ641357 RVA/Human-wt/BGD/MMC6/2005/G2P[4]
 HM467938 RVA/Human-wt/USA/LB2764/2005/G2P[4]
 FJ183355 RVA/Human-wt/ZAF/GR10924/1999/G9P[6]
 KC178785 RVA/Human-wt/ITA/PA83/2007/G2P[4]
85
96
77
72
VP3
 DQ146684 RVA/Human-wt/BGD/N26/2002/G12P[6]
 DQ490547 RVA/Human-wt/BGD/RV161/2000/G12P[6]
 DQ490553 RVA/Human-wt/BGD/RV176/2000/G12P[6]
 DQ005112 RVA/Human-wt/COD/DRC88/2003/G8P[8]
 DQ005123 RVA/Human-wt/COD/DRC86/2003/G8P[6]
 KC178783 RVA/Human-wt/ITA/PA3/2004/G2P[4]
VI
75
100
100
96
 KC178788 RVA/Human-wt/ITA/PA84/2008/G2P[4]
 KC178784 RVA/Human-wt/ITA/PA150/2006/G2P[4]
 HM467936 RVA/Human-wt/USA/LB2744/2005/G2P[4]
 HM467934 RVA/Human-wt/USA/LB2772/2005/G2P[4]
 JF460825 RVA/Human-wt/BEL/F01322/2009/G3P[6] M2
100
99
100
100
100
77
98
 HQ657140 RVA/Human-wt/MWI/1473/2001/G8P[4]
 HQ657173 RVA/Human-wt/ZAF/3203WC/2009/G2P[4]
 AY787654 RVA/Human-wt/CHN/TB-Chen/1996/G2P[4]
 DQ870487 RVA/Human-tc/JPN/S2/1980/G2P1B[4]
II
 HQ650118 RVA/Human-tc/USA/DS-1/1976/G2P1B[4]
 KC178782 RVA/Human-wt/ITA/PAI11/1996/G2P[4] I100
100
87
100
95
 JF304928 RVA/Human-tc/KEN/AK26/1982/G2P[4]
IV EF554106 RVA/Human-wt/HUN/Hun5/1997/G6P[14]
 KC178781 RVA/Human-wt/ITA/PA130/2010/G2P[4]
 FN665690 RVA/Human-wt/HUN/BP1062/2004/G8P[14]
IX
 GU937879 RVA/Goat-wt/BGD/GO34/1999/G6P[1]
 KC178789 RVA/Human-wt/ITA/PA133/2011/G2P[4] V100
100
100
100
97
99
HQ641366 RVA/Human-wt/BGD/MMC88/2005/G2P[4]
VIII FN665679 RVA/Human-wt/HUN/BP1879/2003/G6P[14]
III JF304917 RVA/Human-tc/KEN/D205/1989/G2P[4]
VII EF554084 RVA/Human-wt/BEL/B1711/2002/G6P[6]
M1 GU565065 RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7[5] 
M4 AB009631 RVA/Pigeon-tc/JPN/PO-13/1983/G18P[17]
99
98
81
0.1
(f)
GQ414542 RVA/Human-wt/DEU/GER1H/2009/G8P[4]
JF460814 RVA/Humanwt/USA/06-242/2006/G2P[6]
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segregated into three different lineages within the NSP4 E2
genotype (Fig. 2j, Table 1), with strains PA3/2004, PA150/
2006 and PA83/2007 clustering together with contempor-
ary G2P[4] RVA strains detected all over the world and with
TB-Chen strain isolated in China in 1996, strain PA84/2008
and PA133/2011 clustering with human RVAs from central
and eastern Europe, and strains PA108/2007, PA17/2008
and PA130/2010 segregating with human and ruminant
RVAs from India.
In the VP7 tree, strain PAI11/1996 clustered in the G2-
II lineage, while the 2004–2011 RVAs clustered into two
G2-IV sublineages, diverging by at least 3.1% (nt) from
each other, and including Italian viruses detected in 2004–
2006 (sublineage IVa-1) and in 2007–2011 (sublineage IVa-
3), respectively (Fig. 2a), suggesting temporally related
patterns of segregation. When the VP7 amino acid
alignment (Fig. 3) was inspected in detail, strain PAI11/
1996 was seen to differ only in three residues from the G2
vaccine strain SC2-9 (lineage II) and in 16 residues from
the prototype G2 strain DS-1 (lineage I), with most
changes (3/3 and 10/16, respectively) accumulating within
the variable regions (VRs). The 2004–2011 G2 Italian RVAs
 HM467961 RVA/Human-wt/USA/LB2744/2005/G2P[4]
 HM467963 RVA/Human-wt/USA/LB2772/2005/G2P[4]
 JF835113 RVA/Human-wt/CHN/CC0812-2/2008/G2
86
87
 KC178721 RVA/Human-wt/ITA/PA3/2004/G2P[4]
 HQ657166 RVA/Human-wt/ZAF/3203WC/2009/G2P[4]
 HQ657133 RVA/Human-wt/MWI/1473/2001/G8P[4]
 DQ005108 RVA/Human-wt/COD/DRC88/2003/G8P[8]
 DQ005119 RVA/Human-wt/COD/DRC86/2003/G8P[6]
 KC178723 RVA/Human-wt/ITA/PA83/2007/G2P[4]
100
99
98
NSP1
 KC178726 RVA/Human-wt/ITA/PA84/2008/G2P[4]
 DQ146688 RVA/Human-wt/BGD/N26/2002/G12P[6]
 DQ490540 RVA/Human-wt/BGD/RV161/2000/G12P[6]
 DQ490557 RVA/Human-wt/BGD/RV176/2000/G12P[6]
 FJ183357 RVA/Human-wt/ZAF/GR10924/1999/G9P[6]
 HQ641359 RVA/Human-wt/BGD/MMC6/2005/G2P[4]
II
A2
100
87
80
 HM467962 RVA/Human-wt/USA/LB2764/2005/G2P[4]
 KC178719 RVA/Human-wt/ITA/PA133/2011/G2P[4]
 KC178725 RVA/Human-wt/ITA/PA17/2008/G2P[4]
 HQ641368 RVA/Human-wt/BGD/MMC88/2005/G2P[4]
 KC178724 RVA/Human-wt/ITA/PA108/2007/G2P[4]
 KC178718 RVA/Human-wt/ITA/PA130/2010/G2P[4]
98
96
83
  
 JF460818 RVA/Human-wt/USA/06-242/2006/G2P[6]
 EF554088 RVA/Human-wt/BEL/B1711/2002/G6P[6]
 AY787647 RVA/Human-wt/CHN/TB-Chen/1996/G2P[4]
 JF304921 RVA/Human-tc/KEN/D205/1989/G2P[4]
 KC178720 RVA/Human-wt/ITA/PAI11/1996/G2P[4]
 GQ414546 RVA/Human-wt/DEU/GER1H/2009/G8P[4]
I
100
100
94
99
 HQ650120 RVA/Human-tc/USA/DS-1/1976/G2P[4]
 JF304932 RVA/Human-tc/KEN/AK26/1982/G2P[4]
A3 GU565069 RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7[5]
 GU937883 RVA/Goat-wt/BGD/GO34/1999/G6P[1]
 FN665681 RVA/Human-wt/HUN/BP1879/2003/G6P[14]
 FN665692 RVA/Human-wt/HUN/BP1062/2004/G8P[14]
A11
100
100
100
84
87
EF554110 RVA/Human-wt/HUN/Hun5/1997/G6P[14]
A4 AB009633 RVA/Pigeon-tc/JPN/PO-13/1983/G18P[17]
91
0.1
(g)
KC178722 RVA/Human-wt/ITA/PA150/2006/G2P[4]
JF460829 RVA/Human-wt/BEL/F01322/2009/G3P[6]
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(lineage IV) possessed conserved amino acid differences at
11 residues (seven in the VRs) when compared with strain
PAI11/1996 and 10 conserved different residues (seven in
VRs) when compared with DS-1. In addition, several
scattered variable amino acid mutations were observed.
The two G2-IV sublineages (IVa-1 and IVa-3) possessed
conserved differences at residues in VR1 (position 15) and
VR9 (position 242). Four amino acid changes were observed
throughout the VP7 antigenic epitopes (Aoki et al., 2009)
among the Italian G2P[4] strains and with respect to DS-1
 KC178733 RVA/Human-wt/ITA/PA108/2007/G2P[4]
 HQ641369 RVA/Human-wt/BGD/MMC88/2005/G2P[4]
 KC178727 RVA/Human-wt/ITA/PA130/2010/G2P[4]
99
 KC178734 RVA/Human-wt/ITA/PA17/2008/G2P[4]
 KC178729 RVA/Human-wt/ITA/PA133/2011/G2P[4]
 HQ641360 RVA/Human-wt/BGD/MMC6/2005/G2P[4]
 KC178730 RVA/Human-wt/ITA/PA3/2004/G2P[4]
 KC178735 RVA/Human-wt/ITA/PA84/2008/G2P[4]
 KC178731 RVA/Human-wt/ITA/PA150/2006/G2P[4]
99
NSP2
HM467968 RVA/Human-wt/USA/LB2764/2005/G2P[4]
 HM467967 RVA/Human-wt/USA/LB2744/2005/G2P[4]
 HM467969 RVA/Human-wt/USA/LB2772/2005/G2P[4]
 FJ183361 RVA/Human-wt/ZAF/GR10924/1999/G9P[6]
 DQ490541 RVA/Human-wt/BGD/RV161/2000/G12P[6]
 DQ490558 RVA/Human-wt/BGD/RV176/2000/G12P[6]
II
92
96
91
97
72
 KC178732 RVA/Human-wt/ITA/PA83/2007/G2P[4]
 EF554089 RVA/Human-wt/BEL/B1711/2002/G6P[6]
 DQ005107 RVA/Human-wt/COD/DRC88/2003/G8P[8]
 DQ005118 RVA/Human-wt/COD/DRC86/2003/G8P[6]
 HQ657167 RVA/Human-wt/ZAF/3203WC/2009/G2P[4]
N2
100
99
72
85
83
 JF460819 RVA/Human-wt/USA/06-242/2006/G2P[6]
 JF304922 RVA/Human-tc/KEN/D205/1989/G2P[4]
V GU937884 RVA/Goat-wt/BGD/GO34/1999/G6P[1]
VII FN665694 RVA/Human-wt/HUN/BP1062/2004/G8P[14]
III GU565070 RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7[5]
 HQ650123 RVA/Human-tc/USA/DS-1/1976/G2P[4]
I
100
84
99
98
100
 AY787648 RVA/Human-wt/CHN/TB-Chen/1996/G2P[4]
IV
 GQ414547 RVA/Human-wt/DEU/GER1H/2009/G8P[4]
VI
 JF304933 RVA/Human-tc/KEN/AK26/1982/G2P[4]
 DQ146696 RVA/Human-tc/PHL/L26/1987/G12P[4]
D100
98
99
73
77
 FJ947248 RVA/Human-wt/USA/DC130/1976/G3P[8]
 FJ423131 RVA/Human-tc/Wa/1974/G1P[8]
 KC178728 RVA/Human-wt/ITA/PAI11/1996/G2P[4]
C
B HQ343380 RVA/Human-wt/AUS/AUS_67/1996/G1Px
 HQ343382 RVA/Human-wt/AUS/AUS_48/2001/G2Px
 DQ146689 RVA/Human-wt/BGD/N26/2002/G12P[6] A
N1
100
97
100
91
99
100
N4 AB009625 RVA/Pigeon-tc/JPN/PO-13/1983/G18P[17]
0.05
(h)
HQ657134 RVA/Human-wt/MWI/1473/2001/G8P[4]
JF460830 RVA/Human-wt/BEL/F01322/2009/G3P[6]
 EF554111 RVA/Human-wt/HUN/Hun5/1997/G6P[14]
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and SC2-9 strains, specifically at positions 87 and 96 in
domain 7-1a, 213 in 7-1b and 242 in 7-2, corresponding to
the four amino acids previously recognized as potential
epitopes for G2 strains to be distinguished in lineages and
sublineages (Fig. 3) (Doan et al., 2011).
In the VP4-based tree, strain PAI11/1996 clustered in
lineage P[4]-II, while the 2004–2011 RVAs clustered into
two distinct P[4]-IV sublineages. Strains PA3/2004, PA150/
2006 and PA84/2008 segregated into sublineage IVa, while
the majority of the more recent Italian strains (PA83/2007,
PA108/2007, PA17/2008, PA130/2010 and PA133/2011)
segregated into sublineage IVb (Fig. 2b). When the VP4
amino acid sequences were inspected, overall the G2P[4]
strains isolated in Palermo during the surveillance period
accumulated mutations at seven different amino acid
positions in the antigenic epitopes of VP8* and VP5* with
respect to the ancestor DS-1 strain (lineage I) (Figs 4 and
5). Lineage II strain PAI11/1996 showed two differences
 HM467973 RVA/Human-wt/USA/LB2744/2005/G2P[4]
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from DS-1 in the 8-1 epitope and one in the 8-4 epitope,
and three changes in VP5* epitope 5-1. Five of the amino
acid differences detected in PAI11/1996 were maintained in
sublineage IVa and IVb strains from Palermo which also
differed from DS-1 at residue 133 in epitope 8-3 (N133S),
while position 192 reverted to A as in DS-1. A single
conserved difference was observed between the amino acid
sequences of the IVa and IVb sublineages at position 607
(V607I), outside the VP8* variable region (aa 72–203) and
VP5* epitopes. However, in the VP8* variable region,
residue 162 was either R or G in sublineage IVa sequences
but either R or K in sublineage IVb.
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 HQ657136 RVA/Human-wt/MWI/1473/2001/G8P[4] VI
83
73
NSP4
 KC178749 RVA/Human-wt/ITA/PA83/2007/G2P[4]
 HQ641362 RVA/Human-wt/BGD/MMC6/2005/G2P[4]
 HM467980 RVA/Human-wt/USA/LB2764/2005/G2P[4]
 JF460832 RVA/Human-wt/BEL/F01322/2009/G3P[6]
 JF460821 RVA/Human-wt/USA/06-242/2006/G2P[6]
99
99
94
86
73
I HQ650125 RVA/Human-tc/USA/DS-1/1976/G2P[4]
V KC178746 RVA/Human-wt/ITA/PAI11/1996/G2P[4]
III JF304924 RVA/Human-tc/KEN/D205/1989/G2P[4]
 DQ005105 RVA/Human-wt/COD/DRC88/2003/G8P[8]
 DQ005116 RVA/Human-wt/COD/DRC86/2003/G8P[6]
IX
VIII GU937886 RVA/Goat-wt/BGD/GO34/1999/G6P[1]
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AY787650 RVA/Human-wt/CHN/TB-Chen/1996/G2P[4]
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DQ490560 RVA/Human-wt/BGD/RV176/2000/G12P[6]
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CONCLUSIONS
During a 26-year (1985–2011) surveillance in Palermo,
Italy, the prevalence of G2P[4] RVAs appeared to vary
yearly. An increased prevalence of G2P[4] RVAs was
monitored in 1985 (9.7%), 1996 to 1998 (49%, 35.3%
and 6.7%, respectively), 2003 (22.6%), 2004 (4.9%), 2006
to 2008 (4.3%, 14% and 5.6%, respectively), 2010 (5%)
and 2011 (15.4%). The complete genomes of nine G2P[4]
RVA strains representative of seven different seasons with
increased circulation of G2 RVAs and collected between
1996 and 2011 were used to explore their genetic diversity
in more detail. Based on VP7 phylogeny (Fig. 2a) and
sequence analysis of the VP7 antigenic regions (Fig. 3), the
old strain PAI11/1996 was assigned to lineage II, while the
2004–2006 strains and the 2007–2011 RVAs clustered in
sublineage IVa-1 and sublineage IVa-3, respectively. In-
depth data mining of the sequence databases has revealed
that RVAs of lineage G2-II were circulating mostly during
the 1990s, reaching a global distribution, with the excep-
tion of Asia (Doan et al., 2011). RVAs of lineage G2-IV
dominated globally in the 2000s, with two distinct
sublineages, IVa-1 and IVa-3, emerging consecutively.
The two sublineages differ in their VP7 amino acid
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 HM467920 RVA/Human-wt/USA/LB2764/2005/G2P[4]
H2
99
82
 KC178754 RVA/Human-wt/ITA/PA130/2010/G2P[4]
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99
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KC178759 RVA/Human-wt/ITA/PA108/2007/G2P[4]
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 RVA/Human-wt/CHN/TBChen/1996/G2P[4]
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sequence at position 242 but share, at position 96, the
asparagine residue that disrupts a G2-specific monoclonal
epitope (Arista et al., 2005; Doan et al., 2011). In Italy, G2
RVAs of sublineage IVa-1 circulated from 2004 to 2006
and they were replaced by G2 RVAs of sublineage IVa-3 in
the 2007–2011 period. A similar shift from sublineage G2-
IVa-1 to G2-IVa-3 was also observed on a global scale
approximately in the same period (Doan et al., 2011;
Go´mez et al., 2011; Mascarenhas et al., 2010). Similarly,
upon phylogenetic analysis of the VP4 gene (Fig. 2b) and
sequence analysis of VP4 (Fig. 4), the old Italian strain
PAI11/1996 was classified as a distinct lineage, P[4]-II,
while the 2000s Italian strains were classified into two
different sublineages that emerged consecutively, here
named P[4]-IVa and -IVb. The emergence and spread of
P[4] RVAs of lineage IV during the 2000s has also been
documented elsewhere (Go´mez et al., 2011) and, on the
basis of database interrogation, seems to have occurred
worldwide. Accordingly, there is evidence that in the 2000s
the shift from the VP7 sublineage G2-IVa-1 to G2-IVa-3
occurred in parallel with the shift from the VP4 sublineage
P[4]-IVa to P[4]-IVb, leading to the global spread of a
unique VP7/VP4 combination, G2-IVa-3/P[4]-IVb.
In this study, we tried to understand whether the onset and
spread of recent G2P[4] RVAs was also associated with
reassortment events in their genome. Interestingly, upon
whole genome analysis, the older strain PAI11/1996
displayed not only VP7/VP4 lineages distinct from
contemporary G2P[4] RVAs, but also a distinct genomic
lineage constellation. Strain PAI11/1996 was closely related
to the ancient African strain AK26 in all genome segments
except for NSP2 and NSP4. Strain AK26 was described as a
DS-1-like inter-genogroup reassortant strain with a Wa-
like NSP2 (N1). Also, the VP1 and NSP4 genes of this
African strain appeared to originate from or share a
common origin with RVA genes of artiodactyl (ruminant
and camelid) origin (Ghosh et al., 2011). However, the
NSP2 gene of PAI11/1996 belonged to a different N1
lineage with respect to strain AK26. G2 RVAs with an N1
NSP2 are uncommon but they have been described in
Japan in six consecutive rotavirus seasons, from 1985 to
1990 (Doan et al., 2012). The prototype Japanese inter-
genogroup reassortant G2P[4] strain (AU605) was closely
related to strain TB-Chen, and compared with PAI11/1996
belonged to different lineages in all genome segments
except VP6 (data not shown). These findings are consistent
with the independent origin of the Italian heterotypic NSP2
mono-reassortant strain. Interestingly, in Japan the cir-
culation of NSP2 mono-reassortant strains was observed in
seasons when G2P[4] was not the most prevalent genotype
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*
Fig. 3. Deduced amino acid sequences of the VP7 genes of Italian G2P[4] strains compared with the DS-1 G2 reference and
SC2-9 vaccine strain. Antigenic variable regions (VR) are boxed. Positions of antigenic epitopes 7-1a (red), 7-1b (pink) and 7-2
(blue) and glycosylation sites (yellow) are coloured. Dots indicate conserved positions. Lineages and sublineages within
genotype G2 are indicated as defined by Doan et al. (2011) based on the amino acids at residues 87, 96, 213 and 242
(indicated by asterisks).
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(Doan et al., 2012). Although we have no evidence that all
the G2P[4] strains circulating in Palermo in 1996 were
NSP2 mono-reassortants, VP7 sequencing data from
multiple strains from the 1996 epidemic of G2P[4] suggest
that PAI11/1996 represented the epidemic strains that were
predominant in Palermo in 1996 (Figs 1 and S1).
All the contemporary G2P[4] strains (circulating from 2004
to 2011) belonged to a novel lineage constellation, distinct
from the reference strain DS-1 and from the RVA strains
with DS-1-like genotype constellations circulating in the
1990s. This novel 2000s lineage constellation also included
strains identified from Bangladesh (MMC6), South Africa
(3203WC) and the USA (LB2772), all of which were
circulating in the mid 2000s. Strain LB2772 was closely
related to reassortant G3P[6] RVA strains infecting infants
in Belgium, and to G2P[6] strains identified in the USA in
2006 (Heylen et al., 2013). Interestingly, several DS1-like
non-G2P[4] strains circulating between 1999 and 2003 were
already displaying a similar set of genome segments, thus
suggesting that these novel 2000s G2P[4] viruses were
already circulating at the end of the 1990s. Starting from
2007, several of the Italian G2P[4] strains within this novel
2000s variant of the DS-1-like genotype constellation
proved to be reassortant in one or more gene segments
(VP1, VP3 and/or NSP4) with RVAs of potential artio-
dactyl origin. The number of intra-genotype reassortment
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Fig. 4. Deduced amino acid sequences of the VP4 protein of P[4] strains belonging to different lineages and sublineages.
Positions boxed are situated inside the VP8* variable region (aa 72–203). Residue numbering is based on the RRV sequence
AY033150. Colour coding is used for residues involved in neutralization escape in VP8* (epitope 8-1, green; 8-2, blue; 8-3,
yellow; 8-4, pink) and VP5* (epitope 5-1, white; 5-2 [aa 434], 5-3 [aa 459], 5-4 [aa 429] and 5-5[aa 306], grey).
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events in contemporary G2P[4] RVA strains suggests a
certain tendency to acquisition of gene segments from
animal RVAs when genome segments share the same
genotype. From 2007 to 2011, VP1 and VP3 genes closely
related with a caprine strain (GO34) from Bangladesh and
NSP4 gene segments closely related to those of RVA strains
identified from cows in India were detected in G2P[4]
RVAs of the novel 2000s variant in Palermo. Similarly,
several intra-genogroup reassortment events have been
identified within G2P[4] strains co-circulating in the 2005–
2006 season in the USA (Ba´nyai et al., 2011). The G2P[4]
RVAs circulating in the earlier 2000s appear to be more
homogeneous genetically, suggesting that the G2P[4] RVAs
detected in the 2000s started to acquire novel gene
segments via reassortment only some years after their
global spread. Multi-centric investigations analysing a
larger number of old and novel G2P[4] RVAs detected in
the 2000s from different geographical areas could allow
better explanation of the global evolution of G2P[4] RVAs
in the last decades and eventually reveal additional gene
polymorphisms.
In 2006, two RVA vaccines were licensed and they are now
included as part of the routine vaccination schedule for
infants in many countries around the world (Ciarlet &
Scho¨del, 2009; Heaton & Ciarlet, 2007; Matthijnssens
et al., 2010). None of the currently licensed RVA vaccines
contains strains with a complete DS-1-like genotype
constellation (Matthijnssens & Van Ranst, 2012). In
addition, the VP7 of the SC2-9 G2-reassortant strain of
Rotateq vaccine originates from the tissue culture-adapted
parent human RVA strain SC2, dating back to the early
1980s (Matthijnssens et al., 2010). The G2 VP7 of the SC-2
strain belongs to the same lineage as PAI11/1996 (lineage
II), but this strain appears to be distantly related to
contemporary 2000s G2 strains (Fig. 2), with up to four
amino acid differences being observed in the VP7 antigenic
epitopes of the most recent Italian strains (Fig. 3). A similar
accumulation of mutations in the amino acid sequences of
VP7 was observed in Belgian G2 strains post vaccine
introduction (Zeller et al., 2012). It is unclear whether the
major modifications observed in the neutralizing antigens
and in the genome composition of modern G2P[4] RVAs
are related, to some extent, to the global introduction of
the RVA vaccines. Epidemiological investigations after the
introduction of RVA vaccines have reported increased
circulation of G2P[4] strains in some countries (Gurgel
et al., 2007; Nakagomi et al., 2008; Zeller et al., 2010).
However, long-term surveillance studies indicate that large
fluctuations in the prevalence of G2P[4] RVAs had also
occurred before the introduction of the RVA vaccines
(Ba´nyai et al., 2012).
Large-scale surveillance studies and whole genome sequen-
cing are quickly generating a massive amount of data and
providing new insights into the mechanisms driving the
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evolution of RVAs (Matthijnssens et al., 2008a, 2011). It is
now clear that human RVAs are subjected to a continual
transformation involving accumulation of point muta-
tions, reassortment and repeated intersections with the
evolution of animal RVAs (Martella et al., 2011). On the
basis of our findings, modern G2P[4] RVAs appear to
represent an excellent paradigm of this model.
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